Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system

28 Aug 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Lysosomal Storage Disorders Research
Share to RNA Interference and Gene Delivery

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 30170069
DOI: 10.1016/j.jconrel.2018.08.031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 systemPMID 30170069Read ↗

Efficient CRISPR/Cas9 nickase-mediated genome editing in an in vitro model of mucopolysaccharidosis IVASemantic proximity Read ↗

Genome Editing for MucopolysaccharidosesSemantic proximity Read ↗

CRISPR-Cas9-mediated gene editing in human MPS I fibroblasts.Semantic proximity Read ↗

Therapeutic Genome Editing and In Vivo Delivery.Semantic proximity Read ↗

In Vivo Genome Editing as a Therapeutic Approach.Semantic proximity Read ↗

Neuromuscular disease: CRISPR/Cas9 gene-editing platform corrects mutations associated with Duchenne muscular dystrophy.Semantic proximity Read ↗

A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type ISemantic proximity Read ↗

Genome editing for the reproduction and remedy of human diseases in mice.Semantic proximity Read ↗

Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type ISemantic proximity Read ↗

CRISPR/Cas9 gene editing for curing sickle cell diseaseSemantic proximity Read ↗

Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology.Semantic proximity Read ↗

Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type ISemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.